The purpose of the present study was to define myocardial and blood kinetics after infusion of dipyridamole in normal canine myocardium and in myocardium distal to a coronary artery stenosis. Miniature radiation detector probes were implanted in the left ventricle in 39 open-chest dogs. A balloon constrictor was placed around the proximal left circumflex coronary artery. Electromagnetic flow probes were positioned proximally around both the left circumflex and left anterior descending coronary arteries. In five control dogs (group 1) the balloon occluder was not inflated; in 12 dogs (group 2) a mild stenosis was created such that resting flow was not reduced, yet the hyperemic response after 10 s of total occlusion was partially attenuated; in nine dogs (group 3) a moderate stenosis was created such that resting flow was not reduced, yet the hyperemic response was completely eliminated; and in 13 dogs (group 4) a severe stenosis was created such that resting flow was reduced. After intravenous dipyridamole (0.08 mg/kg . min-1 x 4 min), 1.5 mCi Tl-201 was injected intravenously and probe counts were collected continuously for 4 h. The mean 4-h fractional myocardial Tl-201 clearance for nonstenotic zones was 0.35, 0.27 for group 2 stenotic zones, 0.19 for group 3 stenotic zones, and 0.05 for group 4 stenotic zones (P less than 0.0001). 
A B S T R A C T The purpose of the present study was to define myocardial and blood thallium-201 (Tl-201) kinetics after infusion of dipyridamole in normal canine myocardium and in myocardium distal to a coronary artery stenosis. Miniature radiation detector probes were implanted in the left ventricle in 39 openchest dogs. A balloon constrictor was placed around the proximal left circumflex coronary artery. Electromagnetic flow probes were positioned proximally around both the left circumflex and left anterior descending coronary arteries. In five control dogs (group 1) the balloon occluder was not inflated; in 12 dogs (group 2) a mild stenosis was created such that resting flow was not reduced, yet the hyperemic response after 10 s of total occlusion was partially attenuated; in nine dogs (group 3) a moderate stenosis was created such that resting flow was not reduced, yet the hyperemic response was completely eliminated; and in 13 dogs (group 4) a severe stenosis was created such that resting flow was reduced. After intravenous dipyridamole (0.08 mg/kg. min-' X 4 min), 1.5 mCi TI-201 was injected intravenously and probe counts were collected continuously for 4 h. The mean 4-h fractional myocardial T1-201 clearance for nonstenotic zones was 0.35, 0.27 for group 2 stenotic zones, 0.19 for group 3 stenotic zones, and 0.05 for group 4 stenotic zones (P < 0.0001). After reaching peak activity, myocardial TI-201 activity cleared biexponentially with a final decay constant X2 = 0.0017±0.0001 min-' (SE) for nonstenotic zones, 0.0011±0.0001 min-' for group 2 stenotic zones, and 0.0006±0.0001 min-' for group 3 stenotic zones (P < 0.01). Group 4 stenotic zone Tl-201 clearances were negligible (decay constant essenDr. Pohost is an Established Investigator of the American Heart Association. Address reprint requests to Dr. Okada, Massachusetts General Hospital.
Received for publication 6 May 1981 and in revised form 24 July 1981. tially zero). Blood TI-201 activity decayed triexponentially with a final blood X3 = 0.0018±0.0001 min-1, which was almost identical to the final myocardial X2 decay constant.
Thus, the rate of myocardial TI-201 clearance can distinguish between coronary stenoses of graded hemodynamic severity. These results may be applicable to quantitative techniques for determining myocardial T1-201 clearance rates on serial clinical images after dipyridamole administration.
INTRODUCTION
Clinical imaging with thallium-201 (T1-201) in conjunction with exercise stress is used with increasing frequency for the diagnosis of coronary artery disease (1) . Partial or total disappearance of an initial postexercise TI-201 image defect over time (T1-201 redistribution) suggests transient ischemia (2, 3) . Investigators have also attempted to detect abnormally perfused myocardium by determining the myocardial clearance rates from serial TI-201 images (4-7).
Gould and associates have described TI-201 imaging after an intravenous infusion of dipyridamole, a potent vasodilator (8) (9) (10) . The technique was developed in an effort to improve the diagnostic accuracy of Tl-201 imaging in patients unable to exercise. Tl-201 redistribution was subsequently observed on serial clinical TI-201 images after dipyridamole (11) . Accordingly, the purposes of the present study with dipyridamole and a canine model were (a) to define myocardial and blood Tl-201 clearance kinetics after dipyridamole, (b) to quantitate myocardial TI-201 clearance rates after dipyridamole distal to either nonstenotic or progressively stenotic coronary arteries, (c) to determine the time-course and mechanism of TI-201 heterogeneity resolution after dipyridamole, and (d) left circumflex coronary artery stenosis was created such that resting flow was not reduced, yet the hyperemic response was abolished. In 13 dogs (group 4) a severe left circumflex coronary artery stenosis was created such that resting flow was reduced and there was no hyperemic response. After a 30-min period that allowed stabilization of the hemodynamic parameters, regional myocardial blood flow was then determined by the administration of -4.5 million ruthenium-103-labeled 8-to 10-gm microspheres (30 gCi total activity) into the left atrium (New England Nuclear Corp., North Billerica, Mass.). Arterial reference blood samples were collected for 2 min after injection of the microspheres. An intravenous infusion of dipyridamole (0.08 mg/kg. min-') (Boehringer Ingelheim Ltd., Ridgefield, Conn.) was then started and continued for 4 min using a constant infusion pump. Hemodynamic parameters were recorded during and after the infusion. 2 min after termination of the dipyridamole infusion, T1-201 (1.5 mCi) was injected intravenously and tin-113-labeled microspheres were injected simultaneously into the left atrium. The timing of the dipyridamole infusion and the Tl-201 injection were chosen to approximate that currently used in clinical studies (10) . The total number, mean size, and total radioactivity of the Sn-113 microspheres were approximately the same as for the Ru-103 microsphere injection. Probe counts were collected continuously in 60-s intervals for both the anterior and posterior left ventricular walls over the following 4 h. Proberecorded Tl-201 activity was at least 5,000 cpm for the stenotic zone and at least 10,000 cpm for the nonstenotic zone for all dogs. To measure blood Tl-201 activity over time, 1-ml arterial blood samples were collected at 2, 4, 6, 8, 10, 20, 30, 60, 90, 120, 180, and 240 min after Tl-201 injection. Just before the dogs were killed, scandium-46-labeled microspheres were injected into the left atrium. The total number, mean size, and total radioactivity of the Sc-46 microspheres were approximately the same as for the Ru-103 and Sn-113 microsphere injections.
4 h after Tl-201 injection, the heart was removed, and the areas of myocardium under the probes were subdivided into a total of 48 inner, middle, and outer segments (0.8-1.2 g/ segment). The myocardial and blood microsphere reference samples were counted after TI-201 activity had decayed 1-2 half-lives. Serial blood samples were counted for Tl-201 activity within 12 h of collection. All samples were counted in a well counter (Auto-Gamma Scintillation Spectrometer, Hewlett-Packard Co., Lexington, Mass.) for 5 min to collect at least 10,000 counts for each isotope. The Tl-201 was counted within a 60-120 keV window, the Sn-113 within a 350-435 keV window, the Ru-103 within a 440-600-keV window, and the Sc-46 within a 800- were also analyzed with a computer-derived nonlinear leastsquares estimation of the decay constants (X min-').' The time to peak myocardial Tl-201 activity was defined as the time from Tl-201 injection to the time of maximal probedetermined activity. Analysis of data: time-course and mechanism of thallium-201 heterogeneity resolution after dipyridamole. Because the myocardial probes had different intrinsic sensitivities, the Tl-201 activity ratio for the two zones at the time the dogs were killed as determined by well-counting was used to correct for the differences in sensitivity. The corrected probe activities were then used to calculate the ratio of activity in the left circumflex coronary artery zone (occluder) divided by activity in the left anterior descending coronary artery zone (no occluder) at 10, 60, 120, 180, and 240 min after Tl-201 administration.
Statistical methods. All results are expressed as mean±1 SEM. Differences between groups of dogs were analyzed by a one-way analysis of variance and the Newman-Keuls multiple-comparison test. Differences between the stenotic and nonstenotic myocardial zones for each group of dogs were analyzed by a paired t test.
RESULTS
Hemodynamic response to intravenous dipyridamole. 
202
for the four groups of dogs. Mean heart rate did not significantly differ from the predipyridamole value during dipyridamole or at the end of the experiment in any group. Mean aortic blood pressure fell during dipyridamole (P < 0.05 for groups 3 and 4) but returned to near predipyridamole values by the end of the experiment in all the groups. Mean left atrial pressure and cardiac output increased during dipyridamole, but not significantly in any group. Cardiac output, however, was significantly depressed at the end of the experiment compared with predipyridamole and dipyridamole values for all but the control group of dogs (P < 0.05). Mean left circumflex coronary artery pressure distal to the stenosis fell significantly during dipyridamole in group 3 and group 4 dogs (P < 0.05). Sonomicrometer-determined systolic and diastolic wall thicknesses did not change significantly during dipyridamole infusion or during the course of the experiment for the left venticular anterior and posterior walls monitored for radioactivity. Table II lists the microsphere-determined regional myocardial blood flows for the four groups of dogs. For the group 1 control dogs, there was no significant difference in flow to the left circumflex and left anterior descending coronary artery zones. Myocardial blood flow increased equally and significantly in both zones during dipyridamole (83% over base-line value, P < 0.001). For group 2 dogs, although predipyridamole flows were equal and although myocardial blood flow increased throughout the myocardium during dipyridamole (P < 0.001), there was partial attenuation of the response to dipyridamole in the stenotic zone (51% increase in stenotic zone flow with dipyridamole) (P < 0.01 comparing stenotic with nonstenotic zone flow during dipyridamole). For group 3 dogs, although predipyridamole flows were equal, there was complete attenuation of the hyperemic response to dipyridamole in the stenotic zone. In fact, stenotic zone flow decreased 25% during dipyridamole (P < 0.05). In group 4 dogs, stenotic zone flow was reduced predipyridamole (P < 0.01) and decreased slightly (18%), but not significantly, during the dipyridamole infusion. Fig. 3 demonstrates the myocardial blood flow ratios [left circumflex (stenosis):left anterior descending (no stenosis)] before, during, and 4 h after dipyridamole. Flow ratios during dipyridamole were significantly depressed compared with predipyridamole and 4-h values for groups 2, 3, and 4 (P < 0.001). There was a progressive fall in the flow ratio during dipyridamole progressing from group 1 through group 4 (P < 0.001).
Myocardial and blood kinetics of thallium-201 after dipyridamole. Fig. 4 demonstrates representative myocardial TI-201 time-activity curves photographed from the multichannel analyzer display for the four groups of dogs. Table III lists the T1-201 myocardial and blood clearance data for the four groups of dogs. There was no significant difference in the 4-h fractional myo- g~~~~~Time-course and mechanism of thallium-201 het-| |ẽ r o g e n e i t y resolution after dip yrida mole. Fig. 6 Group3 Grup 4
demonstrates the average myocardial T1-201 clearance Group 3 .Group.
FIGURE 3 Microsphere-determined regional myocardial blood flow ratios (stenosis:no stenosis zones) before, during and 4 h after dipyridamole infusion. There was a progressive reduction in the 4-h fractional myocardial TI-201 clearance for the left circumflex coronary artery zone (balloon occluder) from group 1 through group 4 values (P < 0.0001) (Fig. 5 ). There was no significant difference in the time to peak myocardial T1-201 activity for any of the nonstenotic zones. The mean time to peak myocardial T1-201 activity for all nonstenotic zones was 4.8±0.8 min. There was a progressive increase in the time to peak myocardial T1-201 activity for the left circumflex coronary artery zones (balloon occluder) from group 1 through group 4 values (P < 0.001).
After reaching peak activity, myocardial T1-201 activity cleared biexponentially from the nonstenotic zones (Table III) . The first decay constant XI was 0.0611±0.0080/min, followed by a second decay constant X2 = 0.0017±0.0001/min. The second exponential (X2) began 20±5 min after T1-201 was injected. There was no significant difference in the nonstenotic zone values for XI or X2 for the four groups of dogs.
After reaching peak activity, myocardial T1-201 activity cleared biexponentially from the stenotic zones of groups 2 and 3 dogs. Stenotic zone X, decay constants were smaller than nonstenotic zone XA decay constants, but the differences were not significant. However, there was a progressive reduction in the X2 decay constants for left cirecumflex coronary artery zones (distal to balloon occluder) for group 1 through group 3 dogs (P < 0.01). The 4-h inyocardial clearance of T1-201 from the stenosis zone in group 4 dogs was negligible (decay constaint essentially zero). (16) (17) (18) (19) (20) . Studies in intact, awake dogs have demonstrated no significant fall in systemic arterial pressure with intravenous dipyridamole (9) . Studies in patients have demonstrated minor but significant increases in cardiac output and heart rate and decreases in mean systemic arterial pressure (8, (21) (22) (23) .
Previous studies in normal dogs have demonstrated a 35-400% increase in coronary artery flow with intravenous dipyridamole, depending on the dose and method for calculating flow (16) . These values are consistent with the 83% increase in coronary artery blood flow in control dogs in the present study. As observed in the dogs with mild stenoses in the present study, others have reported an increase in flow with dipyridamole, despite a fall in pressure distal to the stenosis (19, 24, 25) . This phenomenon has been explained by Gould et al. (8) to be due to energy or pressure losses resulting from viscous friction increasing in linear proportion to flow velocity as well as pressure losses due to flow separation increasing as a function of the square of velocity as flow velocity increases through a coronary stenosis. In the present study, the reduction in flow distal to a more severe stenosis (groups 3 and 4) after coronary vasodilatation is consistent with the reports of others (8, 17, 19, 26) . Whether this decreased flow is due to a coronary steal phenomenon or to the decrease in systemic pressure in the face of a severe coronary stenosis is unclear.
The absence in the present study of any significant changes in systolic or diastolic wall thickness during dipyridamole is consistent with the reports of others (16) . West and associates (16) clearance over the first 20 min. First, although blood T1-201 activity was high immediately after tracer injection, the activity then fell rapidly. 3 min after tracer injection blood TI-201 activity was only 5% of myocardial activity (per gram). Second, previous studies of myocardial time-activity curves after TI-201 administration at rest have not demonstrated a biexponential clearance (15) .
As the coronary stenosis became increasingly severe, the present study demonstrated a progressive decrease in the 4-h myocardial TI-201 clearance and in the second myocardial exponential decay constant X2, and a progressive increase in the time to peak TI-201 activity. Okada et al. (15) have reported a decreased clearance rate and a prolongation of the time to peak Tl-201 activity in a resting ischemic model. However, unlike the present study, the resting dog model was unable to differentiate normal myocardium from myocardium distal to coronary stenoses that did not reduce rest flow.
After dipyridamole, TI-201 clearance from the blood was triexponential. The final blood exponential decay constant X3 was similar to the final normal myocardial exponential decay constant X2. Thus, beginning 20-45 min after administration, the rate of TI-201 clearance from the myocardium appears to be related to the rate of TI-201 clearance from the blood. Okada et al. (27) have demonstrated a similar relationship between myocardial and blood T1-201 clearance rates beginning 20-30 min after injection when T1-201 is administered to a normal dog at rest.
Time-course and mechanism of thallium-201 heterogeneity resolution after dipyridamole. With transient or persistent ischemia resting dog models, TI-201 redistribution has been shown to be due to clearance of TI-201 from normal myocardium and slow accumulation of TI-201 in ischemic myocardium (3, 15, 30) . Using an occlusion model with release of the occlusion after TI-201 administration, the initial defect has been demonstrated to rapidly resolve (15) . However, even with persistent stenosis, significant TI-201 redistribution after 4 h in areas with mild to moderate coronary flow reduction has been demonstrated (27) . The present study demonstrates that the resolution of an initial TI-201 heterogeneity after dipyridamole is probably the result of faster TI-201 clearance from normal myocardium compared with myocardium distal to a stenosis. However, although the increases in stenosis:no stenosis zone TI-201 ratio were significant for all three groups of dogs with stenoses, the magnitude of the changes was not great, and none of the groups demonstrated complete redistribution after 4 h. Thus, it is not certain that these significant but small Tl-201 Kinetics after Dipyridamole in Canine Myocardium 207 increases in the stenosis:no stenosis zone TI-201 ratio could have been detected visually as T1-201 redistribution on serial cardiac images, had imaging been performed. Furthermore, the lack of complete resolution of the TI-201 heterogeneity after 4 h suggests that persistent defects on 2-or 4-h TI-201 images may not always represent nonviable myocardium. Clinical implications and conclusions. After dipyridamole, the clearance of T1-201 from normal myocardium is probably biexponential with a mean total clearance of 35% over 4 h. The clearance rate decreases progressively distal to stenoses of increasing severity and differentiates between stenoses of graded hemodynamic severity. These results suggest that newly described quantitative techniques for evaluating serial clinical TI-201 images may be applicable to determining myocardial TI-201 clearance rates after dipyridamole in patients. Such clearance rate determinations may be helpful in determining the hemodynamic importance of a coronary stenosis.
